Nexus Agriscience Expands Molecular Farming with Biotech Institute Hemp IP Acquisition
Nexus Agriscience is making significant strides in molecular farming by acquiring the intellectual property assets of Biotech Institute’s hemp division. This acquisition enhances Nexus’s capabilities in genetics and research and paves the way for the company’s entry into new natural ingredient markets.
Details of the Acquisition
The acquisition includes a robust portfolio comprising:
- Issued and pending utility and plant patents
- Proprietary germplasm
- Living plant materials
- Seed inventory
- Specialized technical expertise
Nexus has successfully integrated these assets following the acquisition, which strengthens its position in the sector.
Strengthening Intellectual Property
The acquired patents are critical for protecting genetic pathways and germplasm. They will enable Nexus to express high-value compounds across primary terpene classes within the cannabis genome. This bolstered intellectual property position supports ongoing investments in Nexus’s molecular farming platform.
Hemp as a Biosynthetic Platform
Nexus Agriscience recognizes hemp as a scalable biosynthetic platform. The company aims to produce non-cannabinoid, hemp-derived natural ingredients for B2B partners. Its operations maintain full vertical control, ranging from genetics to downstream processing.
Environmental and Economic Benefits
The use of hemp as an ingredient alternative to synthetic additives, such as petroleum-based chemicals, enhances its appeal. Additionally, hemp has a favorable carbon profile compared to traditional supply chains. Nexus positions its agricultural model as a capital-efficient alternative to precision fermentation, often associated with high infrastructure costs.
Strategic Leadership Additions
Following the acquisition, several key personnel from Biotech Institute will join Nexus Agriscience:
- Gary Hiller will join the board of directors
- Dr. Mark Lewis will lead genetic development
- Steven Haba will oversee operational execution
Company Background and Future Outlook
Nexus Agriscience was founded in 2019 as Terpene Belt Farms and transitioned to its current name in 2025 after acquiring Biotech Institute’s hemp division. This strategic move is expected to accelerate its market expansion and enhance its product offerings.
CEO Insights
Shareef El-Sissi, Nexus’s CEO, emphasized that this acquisition broadens their platform and alleviates constraints. It allows for quicker market entry while maintaining capital efficiency and scalability. Dr. Mark Lewis added that their engineered hemp model would transform plants into efficient production systems, significantly accelerating manufacturing processes.
